Vycor Medical (VYCO) Change in Account Payables (2010 - 2026)
Vycor Medical's (VYCO) quarterly Change in Account Payables came in at $12571.0 in Q1 2026, little changed year-on-year from $12571.0 in Q1 2025, and up 255.87% on a QoQ basis from -$8065.0 in Q4 2025.
Vycor Medical (VYCO) Change in Account Payables (2010 - 2026) Analysis & Trends
Vycor Medical (VYCO) has 17 years of Change in Account Payables data on file, last reported at $12571.0 in Q1 2026.
- On a quarterly basis, Change in Account Payables changed 0.0% year-over-year to $12571.0 in Q1 2026; TTM through Mar 2026 was -$62813.0, a 307.25% decrease from a year earlier, with the FY2025 full-year figure at -$62813.0, down 311.01% from the prior year.
- Change in Account Payables for Q1 2026 stood at $12571.0, up from -$8065.0 in the prior quarter.
- Over the last five years, Change in Account Payables for VYCO reached as high as $63053.0 in Q2 2022 and fell as low as -$119323.0 in Q4 2023.
- Historically, Change in Account Payables has averaged -$10703.8 across 5 years, with a median of -$7675.0 in 2024.
- Across the five-year window, Change in Account Payables jumped 409.49% in 2022 and sank 529.24% in 2023, its largest moves.
- Year by year, Change in Account Payables stood at -$18963.0 in 2022, then sank by 529.24% to -$119323.0 in 2023, then soared by 93.57% to -$7675.0 in 2024, then fell by 5.08% to -$8065.0 in 2025, then surged by 255.87% to $12571.0 in 2026.
- Per Business Quant data, the three most recent Change in Account Payables figures were $12571.0 in Q1 2026, -$8065.0 in Q4 2025, and -$17221.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.38 Bn | 176.08 Bn | 6.27 Bn | - |
| 2 | Stryker | 129.56 Bn | 126.68 Bn | 3.81 Bn | -198.00 Mn |
| 3 | Medtronic | 109.00 Bn | 99.78 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 68.59 Bn | 67.13 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 47.58 Bn | 43.90 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.65 Bn | 27.53 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 28.55 Bn | 26.27 Bn | 1.98 Bn | 221.00 Mn |
| 8 | Smith & Nephew | 27.05 Bn | 26.48 Bn | - | - |
| 9 | Koninklijke Philips | 25.59 Bn | 22.46 Bn | 2.07 Bn | - |
| 10 | Vycor Medical | 2.34 Mn | 2.16 Mn | 375,153.00 | 12,571.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12,571.00 |
| Mar 31, 2026 | 12,571.00 |
| Dec 31, 2025 | -8,065.00 |
| Dec 31, 2025 | -8,065.00 |
| Sep 30, 2025 | -17,221.00 |
| Sep 30, 2025 | -17,221.00 |
| Jun 30, 2025 | -50,098.00 |
| Jun 30, 2025 | -50,098.00 |
| Mar 31, 2025 | 12,571.00 |
| Mar 31, 2025 | 12,571.00 |
| Dec 31, 2024 | -7,675.00 |
| Dec 31, 2024 | -7,675.00 |
| Sep 30, 2024 | 12,571.00 |
| Sep 30, 2024 | 12,571.00 |
| Jun 30, 2024 | 12,841.00 |
| Jun 30, 2024 | 12,841.00 |
| Mar 31, 2024 | 12,031.00 |
| Mar 31, 2024 | 12,031.00 |
| Dec 31, 2023 | -119,323.00 |
| Dec 31, 2023 | -119,323.00 |